Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Inventory: 2015-2025

Historic Inventory for CorMedix (CRMD) over the last 9 years, with Sep 2025 value amounting to $28.9 million.

  • CorMedix's Inventory rose 334.87% to $28.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.9 million, marking a year-over-year increase of 334.87%. This contributed to the annual value of $7.6 million for FY2024, which is N/A change from last year.
  • Per CorMedix's latest filing, its Inventory stood at $28.9 million for Q3 2025, which was up 200.14% from $9.6 million recorded in Q2 2025.
  • CorMedix's 5-year Inventory high stood at $28.9 million for Q3 2025, and its period low was $269 during Q3 2022.
  • Its 2-year average for Inventory is $9.5 million, with a median of $7.5 million in 2025.
  • Per our database at Business Quant, CorMedix's Inventory crashed by 99.45% in 2022 and then soared by 334.87% in 2025.
  • Quarterly analysis of 4 years shows CorMedix's Inventory stood at $3,008 in 2021, then crashed by 99.45% to $269 in 2022, then reached $7.6 million in 2024, then skyrocketed by 334.87% to $28.9 million in 2025.
  • Its Inventory stands at $28.9 million for Q3 2025, versus $9.6 million for Q2 2025 and $7.5 million for Q1 2025.